Singh Shawn 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2022-12-30$0.09/sh+5,000$438→ 158,998 total
Holdings
- 626,234(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").